Purpose: The purpose of the project was to develop and implement an HIV order set to minimize medication prescribing errors. Methods: A consensus panel of 7 specialists participated in the order-set content and design for EPIC. The order set and policies were approved by the institutional pharmacy and therapeutics committee. A post-implementation consensus evaluated the HIV order set for ease of use, accuracy, and completeness. Results: An IT pharmacist developed the HIV order-set. To create the enhanced decision support tool and functionality in EPIC approximate builder time was 40 hours. Post-evaluation showed that an unavailable product such as ritonavir capsule is still orderable in the orderset. Many new products need to be added to the order-set due to the fast growing in the antiretroviral drug discovery area. Conclusion: In order to design the order-set aiming to prevent the chance of virological failure in the inpatient with HIV, it was important to strategically identify a team including both inpatient and outpatient representatives for the development and evaluation of the HIV order-set. It was critical to have an IT pharmacist specialist to support the design of building necessary and facilitate the update practice guidelines with the clinical team.
Background
HIV management has been revolutionized over the past two decades due to increasing numbers of antiretroviral (ART) agents with improved tolerability. With advances in treatment options and increased understanding of the disease, HIV has become a chronic condition, revealing a new set of challenges for health care professionals 1 . However, several studies have shown that medication errors in hospitalized HIV-infected patients continue to be problematic [1] [2] [3] [4] [5] [6] [7] . It becomes more critical in this population to prevent virological failure and drug resistance. A 2014 review article evaluating 25 studies concerning medication errors in hospitalized HIV patients from 2000-2013, showed the overall incidence of medication errors ranged between 5.8% and 86% including both antiretroviral therapy(ART) and prophylaxis against opportunistic infections (OIs) 1 .
The study that reported a relatively low error rate of 5.8% might be explained by the fact that staff pharmacists who have a lack of clinical expertise or training in patients with HIV we're not be able to identify potential problematic orders 1 . The most common errors included antiretroviral dosing, scheduling, drugdrug interactions, and drug-food interactions 1 .Similarly, in our institution found that missing doses (20%), under-dosing (13%), overdosing(13%), therapy omission(13%), and drug-drug interactions (12%) were the most prevalent ART errors at our teaching institution with 54% occurring on admission and 80% starting at prescribing of the medications 4 . This study also found that the service with a standardized admission order set did not experience any medication errors compared to the other services with no standardized order set. At Johns Hopkins
Hospital in 2009, Yehia et al. found that errors occurred in 29% of admissions on the first 24 hours and in 7% on the second day (24 to 48 hours) of admissions 3 . Akanit et. al. 3 Although the hospital implemented Eclipsys® Sunrise Clinical Manager, a computerized provider order entry (CPOE) system, equipped with a number of clinical support tools which alert providers to potential drug-drug interactions and calculated creatinine clearance at the time of order entry, the system does not flag incomplete ART regimens, dosing, or scheduling errors 3 .The most common error was an incomplete regimen (58%), followed by incorrect doses (38%), incorrect Although CPOE has been implemented in our institution with other system improvements, ART-related medication errors still occur due to lack of knowledge of providers 4, 21-22 as well as the limited availability of HIV specialists. The development and implementation of an HIV order set in our teaching hospital, by translating research-based guidelines into daily practice, would be a potential tool to minimize medication prescribing errors, potential drug interaction, prevent unwanted adverse events, and prevent treatment failure in this patient population.
The secondary goal is to increase awareness of HIV/AIDS management by all healthcare providers within our institution on the complexity of a treatment regimen, layers of dosing for renal drug interactions, and appropriate cocktails are written for the patient when admitted.
Methods

Setting Design
An850-bed tertiary care teaching hospital located in North Central Florida provides services across northeast and north-central Florida. It is estimated that 340adult HIV-infected patients are hospitalized per year, a doubling in census size compared to 10 years ago. The hospital implemented a CPOE (EPIC) for order entry and electronic patient charts. 
Team Selection
The HIV order set team included each inpatient and outpatient services for two Infectious Disease physicians, two HIV/infectious disease pharmacists, and an informatics pharmacy specialist. In addition, two pharmacists specializing in internal medicine assisted in the review and identification of medication-related errors in regards to admission and discharge reconciliation.
Order set Design
The order set was designed based upon the April 2015 guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents (aidsinfo.nih.gov) 23 , the Florida/Caribbean AIDS Education and Training Center (AETC) pocket guides 24 , medication package inserts, and drug monographs [25] [26] [27] .
A consensus panel of the above mentioned 7 specialists participated in the order set content and design for EPIC. The consensus building used the Delphi approach for the process of decision making to identify problems that were common and preventable in the hospital and community settings 28 .
After a first draft of the order set was created, the team met every month for 3 months (3 meetings) to provide input and make revisions based on their expertise.
A 7-page outline draft of the order set is in Appendix A and was used as a road map for the content and alert pathways for electronic development of the order set. The panel identified problems based on previous study insight from Snyder and colleagues and current issues with newer agents and treatment standards 4 . Akanit et. al. 7 The problems, how to best solve them, and what was feasible, clinically and financially, were discussed using the theory of constraints to prioritize problem resolution considering the best method for error prevention and not shifting errors due to technology. We identified and discussed our current constraints.
Order Set Development
A draft of the order set was developed for the IT pharmacist as seen in Appendix A. The goal of the group was to implement key clinical decision support (CDS) tools within the order set to guide providers on best practices when ordering ART medication. Examples of CDS included prompts to review and/or order HLA-B*5701results prior to ordering abacavir, renal dose recommendations, and drugdrug and drug-food interaction information when applicable.
When ordering abacavir, there is a prompt to inform the provider to review HLA-B result if available or order prior to initiating drug. Dose recommendations are provided for ART medications requiring renal dose adjustment (e.g., tenofovir, emtricitabine), as seen in Appendix A. The alert will notify a provider when they order the tenofovir-or lamivudine-containing combination products for a patient with a certain threshold of creatinine clearance (usually below 50 mL/min). Then, the order set would recommend using separate ARV agents with a renal dosing guidance. Drugs that require special instructions regarding food intake have customized administration instructions.
In terms of drug-drug interactions, for example at azanavir (ATV) and proton pump inhibitors (PPIs), there is alert text indicating that PPI is contraindicated. Details on how other acid lowering agents should be used with interacting ART medications are also provided. The safety benefits expected to be derived through use of this order set warranted methods to encourage its use throughout the organization. A proposal to require that all ART used for the management of HIV for inpatients must be ordered through the order set was presented to the Pharmacy and Therapeutics (P&T) Committee. This request was approved and an alert was put in place that requires providers to use the order set when attempting to order individual ART medications outside of the order set.
Post Evaluation
After the HIV order set went live, the pharmacists and the prescribers both entering orders and using the order set reviewed and provided a feedback for ease of use, accuracy, and completeness of the order set.
Results
Order set Design
A detailed COES was created to improve ARV prescribing habits and computer-related errors. In addition, other system improvements have been made to prevent ARV-related medication errors (e.g., timing of liquid medication cart fill, NF inclusion, and medication reconciliation, automated pharmacist review upon verification, CPOE, and drug interaction drug software optimization). Akanit et. al. 9 In the academic hospital medication reconciliation for patients on ARV is completed by ID pharmacists who alert prescribing staff to the need for order correction. The COES was developed to facilitate the initial pharmacist verification process to prevent the errors from occurring and alerting to HIV pharmacist systematically.
Order Set Development
The following figures 1-6are screens shots to illustrate how the order set appears for order entry. The HIV order set was developed by an IT pharmacist from an order set outline in appendix A. To create the level of decision support and functionality in EPIC approximate builder time was approximately 40 hours. This shows how the links are organized in EPIC. During a meeting prior to the "go live"
for the order set the following were discussed, a consensus was reached to 1) add the name of the individual agents after the class of agents, 2) ensure that a minimum of 2 NNRTIs are selected, 3) a link for the AETC pocket prescribing guide, and 4) all new regimens require ID approval. From start to once the order set was implemented occurred over a year. This included 1) initial planning meetings, 2) creating the content as seen in Appendix A, 3) presenting to the PT&T committee, 4) 2 meetings to review and finalize the order set, and 5) and implementing the order set. A second PT&T approval was necessary for an additional policy change of all new ARV starts require ID consultation. 
Implementation: Post Evaluation
The pharmacist reviewed the order set after go-live
After the order set went live in EPIC, an infectious disease (ID) specialized pharmacist reviewed the order set and provided a feedback that due to the rapid evolution in the world of HIV, there are many new ARV medications become available in the market. For instance, tenofovirala fen amide, a renal-friendly tenofovir, got approved to use in two combination products e.g., Genvoya®, and
Odefsey®. It is necessary to have those new ART drugs available for the patient who is admitted to the hospital. Thus, the IT pharmacist and ID pharmacist need to continue working together in order to update the order set based on what are commonly being used in the outpatient setting as well as hospital formula availability.
The prescribers both entered orders using the HIV order set
An outpatient ID specialist provided the feedback that the order set as it was viewed from the outpatient clinic still has an orderable ritonavir capsule which is no longer used in HIV treatment. This might be due to EPIC assigns different workspace between inpatient and outpatient setting. The outpatient provider cannot access the inpatient EPIC view. However, the availability of the order set only in the inpatient setting may lead to a potential issue in a transition of care in the patient who is admitted to the hospital and discharged home. The provider also supports that the order set need to have new ART products that available to use in the outpatient setting.
Discussion
Order Set Design
Published literature suggests that errors in antiretroviral administration in the hospital setting predominately occur on admission with the majority of errors occurring at the prescribing node of the medication use process 3-4 . Having a clinical pathway and prioritizing specific alert messages, we hope to prevent medication errors related to dosing, selection, and timing of administration from occurring in addition to the other system improvements currently in place as shown with Guo and colleagues 13 . Akanit et. al. 13 Given the growing number of patients with HIV on ARV in our institution similarly to the study by Commers and colleagues, our team expects that the clinical pathway order set would be an initial tool for error prevention which could potentially happen before the consultation identifying if consultation is necessary and if necessary simplifying the process 7 .Ideally, this would in turn decrease the ID pharmacist time spent(typical: 1.5-2 hours per patient with HIV on ARV for the medication reconciliations on admission). This time is spent identifying what the patient should be taking to whether it is appropriate and the action necessary to resolve the potential or actual problem. In addition, having the right team of specialists is crucial for the order set development to look through the potential problems and improve the order set after implementation in the clinical setting.
Order Set Development
The HIV order set provides alerts to guide the focus and questions when resolving problems while conducting the medication reconciliation on admission.
The incorporation of all of the complexities of ARV therapy into an electronic order set that enhances decision support is novel method to our institution when compared to the historical practice of ordering them one either from within the electronic health record or on paper. We work to improve admission medication reconciliation electronic accuracy to aid the discharge medication reconciliation. In addition, to pharmacist-led medication reconciliation and order entry via the HIV order set on admission, ongoing monitoring for medication errors by clinical pharmacists throughout the entire hospitalization is necessary. Brennan and colleagues found that, for the 14-patients prescribes incorrect regimens during hospitalization; 86% were discharged with the wrong drug regimen 31 . Incorrect antiretroviral regimens at the time of discharge may lead to ongoing errors in the community setting, thus increasing the likelihood of treatment failure.
Implementation: Post Evaluation
In our hospital as suggested in an earlier study by Snyder et al 4 , many strategies have been implemented including appropriate medication reconciliation, availability of ART medications on the hospital formulary, monitoring during transition of care points especially for discharge medication reconciliation, drug-drug and drug-drug interaction alters, and time when bulk liquids are prepared and sent to the floor. These system improvements require re-evaluation as care evolves based on the population being served. The individual conducting the medication reconciliations is in a position to report back on the nature of the errors as one method of keeping the order set up-to-date.
We proposed in addition to the HIV specialist reporting medication errors that are still occurring or as a result of order set-related confusion that after the annual AETC spring updates a meeting is held to list the necessary order set changes. Given the nature of HIV-related medication, this order set would require a minimum annual update. We experienced if appropriate prescriber order set awareness and education is not provided many will be unaware the order set is available as a resource tool. Strategically, contacting the chairs of departments to identify ideal times to provide prescriber awareness for use is recommended.
Limitation
A limitation of the order set at this time is that the order set mainly focus on ART agents which does not include OIs prophylaxis regimens. Adding OIs prophylaxis regimens into the HIV order set would be another potential quality improvement project in the future to guide differentiating from treatment and prophylaxis dosing. Akanit et. al. 15 Follow-up studies after the order set is live are warranted to assess the practicality in use and redesign the order set if necessary. Future studies are also needed to evaluate the impact of the order set for preventing medication errors.
Conclusion
In order to design the order set aiming to increase the chance of biological suppression in the inpatient with HIV, it was important to strategically identify a team including both inpatient and outpatient representatives for the development and implementation of the HIV order set. It was critical to have an IT pharmacist specialist to support the design of building necessary to aid in the ordering and verifying process. A Follow-up study after our interventions have been made is warranted. 
